The p75 neurotrophin receptor regulates neuronal survival, promoting it in some contexts yet activating apoptosis in others. The mechanism by which the receptor elicits these differential effects is poorly understood. Here, we demonstrate that p75 is cleaved by g-secretase in sympathetic neurons, specifically in response to proapoptotic ligands. This cleavage resulted in ubiquitination and subsequent nuclear translocation of NRIF, a DNA binding protein essential for p75-mediated apoptosis. Inhibition of g-secretase or expression of a mutant p75 resistant to this protease prevented receptor proteolysis, blocked NRIF nuclear entry, and prevented apoptosis. In contrast, overexpression of the p75 ICD resulted in NRIF nuclear accumulation and apoptosis. The receptor proteolysis and NRIF nuclear localization were also observed in vivo during naturally occurring cell death in the superior cervical ganglia. These results indicate that p75-mediated apoptosis requires g-secretase dependent release of its ICD, which facilitates nuclear translocation of NRIF.
Introduction
The 75 kDa neurotrophin receptor (p75) is a multifunctional signaling protein that interacts with numerous ligands and coreceptors to regulate cellular survival, neurite outgrowth, and myelin formation (Barker, 2004) . P75 can bind members of the neurotrophin family, including NGF, brain-derived neurotrophic factor (BDNF), Neurotrophin-3 (NT3), and Neurotrophin-4 (NT4) on its own or in a complex with members of the Trk tyrosine kinase neurotrophin receptor family (Chao and Hempstead, 1995) . It can also serve as a coreceptor for myelin proteins, which bind to the Nogo receptor (Wang et al., 2002; Wong et al., 2002) , and recently, p75 was shown to function in a complex with the neurotensin 3 receptor, Sortilin, in binding to the proform of NGF (Nykjaer et al., 2004) and BDNF (Teng et al., 2005) . These various ligands and coreceptors help determine the cellular effect of p75 activation, although the molecular mechanisms are not well understood.
The ability of p75 to regulate neuronal survival is critical for the normal development of the vertebrate nervous system. Approximately 50% of the neurons generated during embryogenesis are eliminated as a normal pruning process (Oppenheim, 1991) . The attrition of these cells occurs as a result of a limited supply of neurotrophic factors, as well as by active elimination through stimulation of p75. Based on analysis of p75 2/2 mice, this receptor has been implicated in the naturally occurring cell death of neurons in the developing sympathetic ganglia (Bamji et al., 1998; Majdan et al., 2001) , retina (Frade et al., 1996; Frade and Barde, 1998) , spinal cord , and basal forebrain (Yeo et al., 1997; Naumann et al., 2002) . P75 also induces apoptosis following a number of CNS injuries, such as after spinal cord lesion (Beattie et al., 2002; Harrington et al., 2004) or pilocarpine-induced seizures (Troy et al., 2002) .
Despite these numerous functions with important physiological consequences, p75 signaling mechanisms remain poorly understood. In an effort to understand how the receptor transduces its signals, a number of proteins have been identified that can bind to its intracellular domain (ICD) (Gentry et al., 2004a) , and several of these have been implicated in apoptosis, including NRIF (Casademunt et al., 1999; Linggi et al., 2005) , TRAF6 (Khursigara et al., 1999; Yeiser et al., 2004) , Rac , NADE (Mukai et al., 2000) , and the MAGE family members NRAGE (Salehi et al., 2000) and Necdin (Tcherpakov et al., 2002; Kuwako et al., 2004) . Based on analysis of the nrif 2/2 mice, NRIF was shown to be essential for p75-mediated apoptosis in the developing mouse retina (Casademunt et al., 1999) and sympathetic neurons from the superior cervical ganglia (Linggi et al., 2005) . NRIF is a DNA binding protein (Williams et al., 2004, Soc. Neurosci., abstract) , and when ectopically expressed in nontransformed cells, including sympathetic neurons, it is localized in the nucleus, in part, and induces apoptosis (Linggi et al., 2005) . Moreover, preventing NRIF's nuclear entry abrogated its ability to kill neurons (Geetha et al., 2005) . Thus, although NRIF binds to the ICD of p75 and is an essential component of the receptor's apoptotic signal, it appears to function in the nucleus, raising the question as to how it gets there.
A number of cell surface receptors transmit their signals to the nucleus by a direct mechanism, in which the ICD is liberated by g-secretase mediated intramembrane cleavage and translocates to the nucleus; e.g., Notch, amyloid precursor protein (APP), and Erb-B4 (Fortini, 2002) . Recently, phorbol ester treatment of cell lines expressing p75 was shown to induce a sequential cleavage of the receptor, first by the metalloprotease TACE (Weskamp et al., 2004; Zampieri et al., 2005) , followed by g-secretase, resulting in release of its ICD (Jung et al., 2003; Kanning et al., 2003) . However, the physiological significance of this proteolytic processing remains to be determined.
Here, we report that proBDNF and BDNF induce apoptosis of sympathetic neurons, which is accompanied by g-secretase mediated cleavage of p75 and NRIF nuclear localization. Preventing the cleavage blocks NRIF nuclear entry and the subsequent apoptosis. These findings suggest that, like Notch and APP, p75 activates a pathway directly to the nucleus through g-secretase mediated release of its ICD and that this signal is necessary for nuclear translocation of NRIF, leading to apoptosis.
Results

Proapoptotic Ligands Induce Cleavage of P75 by g-Secretase in Sympathetic Neurons
Previous studies demonstrated that phorbol ester treatment of cell lines expressing the p75 neurotrophin receptor induced its proteolytic processing, first by TACE, shedding the extracellular domain and leaving a 30 kDa membrane bound carboxy-terminal fragment (CTF) (DiStefano and Chelsea, 1990; DiStefano et al., 1993; Weskamp et al., 2004; Zampieri et al., 2005) . Subsequently, the CTF was cut in the transmembrane domain by the g-secretase complex, releasing a soluble 25 kDa ICD (Jung et al., 2003; Kanning et al., 2003) . We investigated whether phorbol ester would similarly induce cleavage of endogenous p75 in sympathetic neurons, isolated from rat superior cervical ganglia. Within 30 min of PMA treatment, two p75 fragments, at approximately 30 kDa, the size of the CTF, and 25 kDa, the size of the ICD, were detected ( Figure 1A ). As previously reported (Jung et al., 2003; Kanning et al., 2003) , these fragments were rapidly degraded and could only be detected by pretreating the neurons with a proteasome inhibitor.
We next investigated whether neurotrophin treatment could activate the cleavage of p75. Sympathetic neurons were initially cultured in NGF, but in order to evaluate the effect of neurotrophin binding specifically to p75, without any influence of their binding to TrkA, which is expressed on these neurons, we removed the NGF and maintained the neurons in 12.5 mM KCl. Under these conditions, we did not observe any basal cleavage of p75, even after 24 hr in the presence of the proteasome inhibitor; however, treatment with proBDNF or BDNF, which selectively bind to p75, induced cleavage of the receptor ( Figures 1B and 1C) . As with PMA, the intracellular fragments were not detectable unless a proteasome inhibitor was present. Curiously, the proteolytic products were not observed until 12 hr of treatment, suggesting other signaling mechanisms precede the cleavage. We also confirmed that the lower molecular weight bands were not products of the highly homologous NRH2/PLAIDD protein (Kanning et al., 2003; Frankowski et al., 2002) , which might be recognized by our p75 ICD antibody ( Figure 1E) .
In contrast to proBDNF or BDNF, which induce apoptosis of sympathetic neurons, readdition of NGF, which promotes survival through binding to the p75-TrkA complex, did not activate proteolysis of the receptor (Figure 1D ). This did not reflect an inherent inability of this neurotrophin to stimulate receptor processing because NGF treatment of RN22 Schwannoma cells also induced the cleavage ( Figure S1A ). These cells do not express TrkA; therefore, it is likely the presence of TrkA in the neurons that prevents NGF from stimulating p75 proteolysis, consistent with previous findings that TrkA expression inhibits p75 cleavage by g-secretase (Kanning et al., 2003) .
The 25 kDa fragment of p75 observed in response to BDNF or proBDNF treatment was confirmed to be a product of g-secretase cleavage by preincubating the neurons with the g-secretase specific inhibitors Compound E (Seiffert et al., 2000) or DAPT (Dovey et al., 2001) . Neither of these compounds had any effect on their own, but both blocked the formation of the smaller, ICD fragment in response to ligand (Figures 2A, 2B , and 5C).
Cleavage of P75 by g-Secretase Is Necessary for NRIF Nuclear Translocation in Response to Ligand P75-mediated apoptosis in sympathetic neurons requires NRIF (Linggi et al., 2005) , a novel zinc finger protein identified based on its association with the ICD of p75 (Casademunt et al., 1999) . The ability of NRIF to localize to the nucleus (Casademunt et al., 1999; Gentry et al., 2004b; Geetha et al., 2005) led us to hypothesize that its nuclear translocation in response to p75 activation was dependent on g-secretase-mediated cleavage of the receptor. To test this hypothesis, we treated neurons with proBDNF in the presence and absence of Compound E, the g-secretase inhibitor. By immunolocalization, we found that NRIF was exclusively in the cytoplasm of neurons cultured with KCl ( Figure 2C ) or NGF ( Figure 8D ). Following the addition of proBDNF, 90% of the neurons exhibited nuclear accumulation of NRIF; however, this translocation was completely blocked in the presence of Compound E ( Figures 2C and 2D ). To further verify the nuclear localization of NRIF after proBDNF treatment, we prepared nuclear extracts, and NRIF was detected by immunoprecipitation and Western blotting. NRIF was only detected in nuclear lysates after proBDNF treatment ( Figure 2E ).
NRIF Ubiquitination Is Dependent on P75 Cleavage
The nuclear translocation of NRIF, in response to p75 activation, was recently shown to require polyubiquitination by the E3 ligase TRAF6 (Geetha et al., 2005) . The ubiquitin chain formed by TRAF6 is not the canonical lysine 48 linkage, which targets proteins for degradation, but is through lysine 63, which acts more as a protein interaction motif. In sympathetic neurons, we observed NRIF polyubiquitinated in response to BDNF with a time course similar to receptor cleavage (Figure 3A) . To test whether the addition of polyubiquitin to NRIF required prior processing of the receptor, we added Compound E to the neurons, which were then treated with BDNF. As shown in Figure 3A , the g-secretase inhibitor completely ablated ubiquitination of NRIF. In contrast, receptor cleavage was not altered in neurons from traf6 2/2 mice ( Figure 3B ). These results indicate that receptor cleavage is necessary for the TRAF6-mediated ubiquitination of NRIF, but p75 processing occurs independent of TRAF6.
NRIF Binds to the Liberated ICD of P75
The cleavage of Notch and APP by g-secretase allows for the binding of the liberated ICD to transcription factors (Selkoe and Kopan, 2003) , and for APP, this processing serves as a means of shuttling the transcription factor Fe65 into the nucleus (Cao and Sudhof, 2001; Cupers et al., 2001) . Therefore, we hypothesized that after the cleavage of p75, the released ICD would bind to NRIF. Initially, we tested this in 293 cells stably expressing p75. NRIF was transfected into the cells along with TRAF6, which we previously found enhances the expression of NRIF (Gentry et al., 2004b) , and cleavage was induced by PMA. We observed NRIF coimmunoprecipitation with the 25 kDa ICD fragment of p75, as well as with the CTF and the full-length receptor (Figures 4A and 4B) . Inhibiting g-secretase with Compound E prevented the association between the ICD fragment and NRIF ( Figures 4C and 4D ). We also investigated the association of NRIF and p75's g-secretase product in sympathetic neurons. NRIF was detected in immunoprecipitates of p75 in the absence of ligand, reflecting an association of the full-length receptor with NRIF; however, the interaction of NRIF with the ICD was increased after treatment (A) Sympathetic neurons from P3-P4 rats cultured for 2 days with 20 ng/ml of NGF were treated with a proteasome inhibitor (ZLLLH, 10 mM) alone (Con) or with 1 mM PMA for varying times and then lysed and subjected to Western blot analysis with an antibody to the ICD of p75. Based on their predicted molecular weight, the arrows indicate the fulllength receptor (w75 kDa, FL), the carboxyterminal fragment (w30 kDa, CTF), or the intracellular domain (w25 kDa, ICD). (B and C) After 2 days in culture with NGF, the neurons were rinsed to remove the NGF and refed with media containing 12.5 mM KCl, to promote survival, and 10 mM ZLLLH alone (Con) or with 3 ng/ml of proBDNF (B) or 100 ng/ml of BDNF (C). After the indicated times, the neurons were lysed and subjected to Western blot analysis with an antibody to the ICD of p75 (anti-p75 ICD). (D) Sympathetic neurons were maintained in 10 mM ZLLLH alone (Con) or 100 ng/ml of NGF and 10 mM ZLLLH for the indicated time, lysed, and subjected to Western blot analysis with anti-p75 ICD. (E) Lysates from the neurons treated 12 hr as described in (A)-(C) with ZLLLH and 1 mM PMA, 3 ng/ml proBDNF, or 100 ng/ml BDNF were Western blotted with an antibody to NRH2.
with BDNF, likely because of the accumulation of the ICD, and this was reduced by cotreatment with Compound E ( Figure 4E ). Similarly, when NRIF was immunoprecipitated, the full-length receptor was detected with or without BDNF, but the free ICD only associated with NRIF after ligand treatment ( Figure 4F ). Taken together, these findings demonstrate that NRIF associates with p75 and that g-secretase-mediated cleavage of the receptor facilitates an interaction between the free ICD and NRIF.
Inhibition of g-Secretase Prevents P75-Mediated Apoptosis
The selective ability of proapoptotic ligands to induce cleavage of p75 and NRIF nuclear translocation suggested that g-secretase-dependent processing of the receptor was necessary for the cell-death signal in these neurons. In addition, we found that p75-mediated apoptosis in the neurons required 24 hr, no increase in apoptotic nuclei was observed after 12 hr of BDNF exposure (data not shown), which is consistent with receptor cleavage preceding cell death. To test whether p75-processing by g-secretase was necessary for the apoptotic signal, we preincubated the neurons with various concentrations of Compound E and then treated them with proBDNF ( Figure 5A ) or BDNF ( Figure 5B ). Both ligands potently induced neuronal apoptosis, based on evaluation of the nuclei by DAPI staining; however, the cell death was completely blocked by the g-secretase inhibitor, which had no effect on its own. Similar results were obtained with another specific g-secretase inhibitor, DAPT (Figures 5C and 5D) .
Expression of P75's ICD Is Sufficient to Kill Neurons and Induce NRIF Ubiquitination and Nuclear Translocation
Because g-secretase has many substrates, we wanted to rule out the possibility that the g-secretase inhibitors were blocking the proteolysis of some protein other than p75, which may be required for proBDNF and BDNF to induce cell death. Therefore, we assessed whether the expression of the free p75 ICD alone was sufficient to kill the neurons. The p75 ICD was expressed in the sympathetic neurons by using an adenovirus, which was previously shown to elicit cell death in PC12 cells (Roux et al., 2001) . After confirming the expression of the ICD in the neurons ( Figure 6E ), we quantified the apoptotic nuclei 24 hr after the infection and found a significant increase in apoptosis (Figures 6A and 6B) . Compound E had no effect on the cell death induced by expression of the ICD, which indicates that it prevented p75-mediated cell death by blocking cleavage of the receptor as opposed to other substrates.
In agreement with our results with Compound E in the neurons, which demonstrated that p75 cleavage is necessary for NRIF to translocate to the nucleus (Figure 2 ), Figure 2 . Inhibition of g-Secretase Blocks Ligand-Induced P75 Cleavage and Nuclear Translocation of NRIF in Sympathetic Neurons (A and B) Sympathetic neurons were cultured in NGF (20 ng/ml) for 2 days, and then the NGF was rinsed off, and the neurons refed media with 12.5 mM KCl (to promote survival) and 10 mM ZLLLH in the presence or absence of the g-secretase inhibitor Compound E (CpdE). After 1 hr, the neurons were treated with 3 ng/ml of proBDNF (A), 100 ng/ml of BDNF (B), or left untreated. After 12 hr, the neurons were lysed and immunoblotted with an antibody to the p75 ICD. The arrows indicate the full-length receptor (FL), the carboxy-terminal fragment (CTF), or the intracellular domain (ICD). (C and D) Sympathetic neurons maintained in 12.5 mM KCl (Control) were left untreated or incubated with 250 nM of Compound E (CpdE), proBDNF (3 ng/ml), or both (CpdE + proBDNF). After 30 hr, the neurons were immunostained for NRIF (green). The nuclei were labeled with propidium iodide (red). The neurons were then imaged by confocal microscopy (C). (Scale bar, 20 mm). The number of neurons with nuclear NRIF was quantified, and the means 6 SD are depicted in (D). (n = 3; asterisk, p < 0.0005.) (E) Sympathetic neurons maintained in 12.5 mM KCL, as described above, were treated with or without 3 ng/ml of proBDNF for 30 hr, and nuclear extracts were prepared. NRIF was immunoprecipitated and Western blotted with an antibody to NRIF (top). The isolation of nuclei was confirmed by blotting nuclear extracts (NE) and postnuclear supernatant (PNS) for Histone Deacetylase 1 (HDAC 1) and b-actin (bottom).
we observed that the expression of the ICD was sufficient to significantly increase the amount of NRIF in the nucleus (Figures 6C and 6D ). This also corroborates our previous findings that the nuclear localization of NRIF is required for p75-mediated apoptosis (Geetha et al., 2005) .
Because our findings suggested that the mechanism by which NRIF gets targeted to the nucleus, after p75 cleavage, is by the addition of a polyubiquitin chain (Figure 3) (Geetha et al., 2005) , and expression of the ICD alone resulted in NRIF localizing to the nucleus (Figure 6C) , we hypothesized that expressing this receptor fragment must be sufficient to induce NRIF modification. Indeed, we found that when p75's ICD was expressed in neurons by using an adenovirus, NRIF was ubiquitinated ( Figure 6G ). Moreover, in contrast to wild-type neurons, expression of the ICD in neurons from traf6 2/2 mice did not mobilize NRIF to the nucleus ( Figure 6H ), despite similar levels of ICD expression (data not shown). Like the endogenous ICD formed by ligand activation, the ectopically expressed ICD could be coimmunoprecipitated with NRIF in wild-type neurons ( Figures 6E and 6F ). These results, along with those of Figure 3 demonstrating that cleavage is necessary for NRIF ubiquitination, suggest that the proteolytic release of p75's ICD is sufficient to stimulate TRAF6-mediated ubiquitination of NRIF, which facilitates its nuclear translocation.
A Noncleavable Mutant of P75 Blocks the Apoptotic Signal and NRIF Nuclear Translocation
To further confirm that g-secretase must specifically process p75 in order for the receptor to transduce a cell-death signal, we used a p75 mutant reported to be resistant to this protease . This construct is a chimeric receptor of p75 with the Fas transmembrane domain (p75-FasTM). Its resistance to g-secretase was confirmed in 293 cells ( Figure 7A ), and its ability to act as a dominant negative and block the cleavage of endogenous p75 in response to BDNF was demonstrated in RN22 cells ( Figure 7B ). We found that the chimeric receptor was trafficked normally to the plasma membrane, by immunolocalization (Figure 7E ) and by subcellular fractionation ( Figure S2D) ; however, its expression prevented the wild-type receptor from interacting with the g-secretase complex. BDNF treatment of 293 cells expressing p75 resulted in a ligand-dependent interaction between endogenous presenilin 1, a component of the g-secretase complex, and the receptor ( Figure 7C ). In contrast, p75-FasTM did not associate with presenilin, and it prevented the interaction with wild-type p75 ( Figure 7C ). The chimeric receptor coimmunoprecipitated with wild-type p75, indicating that it oligomerizes with the endogenous protein and thereby prevents its interaction with the g-secretase complex ( Figure S2B ).
To determine whether the p75-FasTM could block receptor-mediated apoptosis in sympathetic neurons, we transfected this construct, by electroporation, into the neurons and, after 48 hr, treated the cells with BDNF. GFP-transfected neurons and those cotransfected with GFP and wild-type p75 underwent the expected apoptosis; however, the noncleavable mutant completely protected the neurons ( Figure 7D ). In addition, expression of p75-FasTM prevented nuclear translocation of NRIF in response to proBDNF treatment ( Figure 7E ). These results indicate that g-secretase mediated proteolysis of p75 is essential for the nuclear translocation of NRIF and the subsequent induction of neuronal apoptosis.
Cleavage of P75 and NRIF Nuclear Localization Occur In Vivo during the Period of Naturally Occurring Cell Death In vivo, sympathetic neurons undergo naturally occurring cell death during development and this process has been suggested to depend, at least in part, on p75 (Bamji et al., 1998; Majdan et al., 2001; Yeiser et al., 2004) . Therefore, we hypothesized that receptor cleavage and NRIF nuclear localization should occur during the period of apoptosis in the superior cervical ganglia Figure 3 . Inhibition of g-Secretase Blocks Ligand-Induced NRIF Ubiquitination in Sympathetic Neurons (A) Sympathetic neurons from P3-P4 rat were cultured in 20 ng/ml of NGF for 2 days, and then the NGF was rinsed off, and the neurons refed media containing 12.5 mM KCl (Control) or treated with 250 ng/ml of BDNF for 15 min or 16 hr, with the g-secretase inhibitor Compound E (CpdE, 100 nM) alone, or pretreated 1 hr with Compound E (CpdE) and then treated with 250 ng/ml of BDNF for 16 hr. The cells were then lysed and NRIF immunoprecipitated and Western blotted with anti-ubiquitin (top) or anti-NRIF (bottom). (B) Sympathetic neurons from P4 traf6 2/2 mice were cultured in 20 ng/ml of NGF for 2 days, NGF removed, and refed with media containing 12.5 mM KCl and 10 mM ZLLLH alone (Control) or with 100 ng/ml of BDNF for 12 hr (BDNF). Then, the neurons were lysed and immunoblotted with anti-p75 ICD.
(SCG). Ganglia were isolated from rats at postnatal day 4 (P4), when there is on-going apoptosis, or from day 24 (P24), after neuronal attrition has subsided, and analyzed for p75 proteolysis by Western blotting. The CTF and ICD fragments of the receptor were observed at P4 but not at P24 ( Figure 8A ). This result was rather surprising given that detection of the ICD in culture was not possible without proteasome inhibitors and suggests that a considerable amount of cleavage or a stabilization mechanism must exist in vivo. We also observed numerous neurons with nuclear NRIF at P4, but at P24, no NRIF was detected in the nucleus and the signal was very weak compared to that at P4 ( Figure 8B ). These results are consistent with p75 cleavage promoting NRIF nuclear translocation.
In vivo, the cell death that occurs in the SCG during development is thought to be primarily a result of limited supplies of NGF in the target tissue. Hence, the proteolysis of p75 and the nuclear shuttling of NRIF could be the result of limited NGF. However, we found that NGF withdrawal was not able to induce receptor cleavage ( Figure 8C ) or NRIF movement to the nucleus ( Figure 8D ). This result suggests that the in vivo cleavage and NRIF nuclear translocation is a result of active p75 signaling.
Discussion
The p75 neurotrophin receptor is a key regulator of neuronal apoptosis, both during development and after injury Barde, 2004) ; however, The same lysates were also immunoprecipitated with anti-NRIF and immunoblotted by using the antibody to p75's ICD. (C and D) 293 cells stably expressing the p75 receptor were cotransfected with pcDNA3-NRIF and pFlag-TRAF6. 48 hr later, the cells were pretreated with 10 mM ZLLLH, in the presence and absence of 250 nM Compound E, and after 1 hr, 1 mM PMA was added, or they were left untreated. After 2 hr, the cells were lysed and the lysate immunoprecipitated with an antibody to p75's ICD (C) or NRIF (D) and Western blotted with NRIF or p75 ICD antibody. (E and F) Sympathetic neurons from P3-P4 rats were cultured in 20 ng/ml NGF for 2 days, and then the NGF was removed, and the neurons maintained in 12.5 mM KCl. The neurons were then pretreated with 10 mM ZLLLH, in the presence or absence of 250 nM Compound E, and after 1 hr, 200 ng/ml BDNF was added, or they were left untreated. After 24 hr, the cells were lysed, immunoprecipitated with antisera to the ICD of p75 (E) or NRIF (F), and Western blotted with antibodies to NRIF or p75 ICD. the molecular mechanisms by which it mediates its effects are not well understood.
In this study, we demonstrate that p75's apoptotic signal requires a ligand-dependent cleavage of the receptor by g-secretase, which releases the intracellular domain, resulting in nuclear translocation of the DNA binding protein NRIF through a ubiquitin-dependent mechanism. Thus, p75 joins the rapidly growing list of cell-surface proteins that signal directly to the nucleus through intramembrane proteolysis.
The cleavage of membrane receptors by g-secretase has recently emerged as a novel and highly conserved mechanism in receptor mediated signaling (Fortini, 2002; Ebinu and Yankner, 2002) . Numerous singletransmembrane domain proteins have been shown to undergo this processing (e.g., Notch, APP, Erb-B4, E-cadherin); however, most have only been shown to be cleaved in response to phorbol ester treatment. Only for Notch (Selkoe and Kopan, 2003) and Erb-B4 (Ni et al., 2001 ) has ligand-dependent cleavage been demonstrated. Recently, the p75 receptor was also reported to undergo proteolysis by the g-secretase complex in response to phorbol ester (Jung et al., 2003; Kanning et al., 2003) . Like many substrates of this protease, p75 is first cleaved in its extracellular domain by a metalloprotease (DiStefano et al., 1993) , recently identified as TNFa convertase (TACE/ADAM-17) (Weskamp et al., 2004) . Evidence for a ligand-dependent cleavage was provided by Frade (2005) , who demonstrated that neurotrophins could induce p75 proteolysis in Schwann cells; however, the biological significance of this processing was not addressed. One of p75's other ligands, myelin associated glycoprotein (MAG), which interacts with p75 through the Nogo receptor (Wang et al., 2002; Wong et al., 2002) , was also shown to activate receptor cleavage by g-secretase, and this processing was essential for the inhibition of neurite outgrowth (Domeniconi et al., 2005) . Interestingly, this signal has not been shown to depend on any nuclear events. Thus, the physiological significance of p75 proteolysis in the context of neurotrophin binding and the potential of the receptor to signal directly to the nucleus, similar to other g-secretase substrates, remained unclear.
One of the best characterized biological responses of p75 activation is the induction of cell death. This apoptotic signal requires the activation of c-Jun N-terminal kinase (JNK), which has been suggested to involve the receptor interacting proteins TRAF6 (Yeiser et al., 2004) , Rac , and NRAGE (Salehi et al., 2002) . JNK then phosphorylates Bim (Becker et al., 2004) and Bad (Bhakar et al., 2003) , which promote the release of mitochondrial cytochrome c and caspase activation. Curiously, c-Jun does not appear to be required for p75-mediated apoptosis; however, cycloheximide prevented the receptor from killing sympathetic neurons, suggesting that macromolecular synthesis is necessary (Palmada et al., 2002) . A role for transcription in p75 signaling was also indicated by the fact that several of the proteins that associate with the ICD of the receptor can be found in the nucleus and are thought to regulate gene expression, e.g., NRIF (Casademunt et al., 1999; Gentry et al., 2004b) , SC-1 (Chittka and Chao, 1999; Chittka et al., 2004) , and Necdin (Tcherpakov et al., 2002) . Among these interactors, NRIF has been (A and B) P3-P4 rat sympathetic neurons were cultured for 2 days in 20 ng/ml NGF, and then the NGF was removed and the cells refed with media containing 12.5 mM KCl alone (Ctrl), or with varying concentrations of Compound E (CE), 3 ng/ml proBDNF (PB) (A), 100 ng/ml BDNF (B), or with both Compound E and proBDNF or BDNF (CE+PB or CE+B). 48 hr later, the cells were fixed, stained with DAPI, and apoptotic nuclei quantified. Shown are the means 6 SD, n = 3 (asterisk, p < 0.002). (C and D) Sympathetic neurons, cultured as in (A), were left untreated (Ctrl) or incubated with DAPT, 100 ng/ml BDNF, or both. The neurons were lysed after 12 hr and immunoblotted with an antibody to p75 ICD (C) or treated for 48 hr and then fixed, stained with DAPI, and apoptotic nuclei quantified (D). Shown are the means 6 SD, n = 3 (asterisk, p < 0.002). Figure 6 . Overexpression of the Intracellular Domain of P75 Induces Apoptosis and NRIF Nuclear Translocation and Polyubiquitination in Sympathetic Neurons (A) Sympathetic neurons, cultured 2 days with 20 ng/ml NGF, were infected with an adenovirus expressing p75 ICD or GFP or left uninfected. After 24 hr, the neurons were immunostained with the p75 ICD antibody (green). The nuclei were labeled with propidium iodide (red). The neurons infected with GFP control vector were also immunostained for the ICD of p75 (red). The neurons were then imaged by confocal microscopy. In neurons overexpresssing the ICD of p75 (arrow), there was an increase in p75 ICD immunoreactivity compared to uninfected and GFP-expressing neurons. demonstrated to play an essential role in p75 mediated apoptosis. It is a novel DNA binding protein (Williams et al., 2004, Soc. Neurosci., abstract) with Krü ppeltype zinc fingers that was first implicated in p75's death signal based on the significant reduction of cell death in developing retina of nrif 2/2 mice (Casademunt et al., 1999) , a phenotype similar to that observed in p75 2/2 mice (Frade et al., 1996) . More recently, it was shown that sympathetic neurons from these mice are resistant to p75-induced apoptosis, and ectopic expression of NRIF in primary cell types resulted in its nuclear accumulation and cell death (Linggi et al., 2005) . The nuclear localization of NRIF is essential for p75-mediated cell death because a point mutant of NRIF, unable to translocate to the nucleus, was not able to reconstitute the receptor's death signal in nrif 2/2 sympathetic neurons, but wild-type NRIF could (Geetha et al., 2005) .
These findings raised the question as to how NRIF gains access to the nucleus, given its interaction with the ICD of p75. Our current results reveal an answer, namely, the receptor undergoes a proteolytic cleavage to release its ICD, thereby facilitating NRIF's nuclear localization and the subsequent apoptosis. A similar mechanism for regulating nuclear signaling has been demonstrated for several other substrates of g-secretase. In the case of Notch, the ICD enters the nucleus and binds a repressor complex (CSL) and a coactivator (Mam), thereby activating Notch target genes (Selkoe and Kopan, 2003) . In a manner more analogous to p75, the ICD of APP binds to a transcriptional coactivator, Fe65, and tethers it in the cytosol. After APP cleavage, Fe65 mobilizes to the nucleus and, together with the histone acetyltransferase Tip60, activates gene transcription (Cao and Sudhof, 2001) .
For all of these g-secretase substrates, detecting the endogenous ICD in the nucleus has proven technically difficult because it is rapidly degraded and only a small fraction, if any, enters the nucleus (Schweisguth, 2004) . Although for Notch, there is convincing evidence that its ICD translocates to the nucleus, in the case of many of the other proteins, it remains controversial. In our experiments, we have not been able to detect any significant amount of p75's ICD in the nucleus, even when overexpressing the ICD alone ( Figure 6A ); however, it remains possible that a fraction is present, below our detection limits.
The ligand-induced cleavage of p75 was surprisingly slow, being undetectable until 12 hr (Figure 1 ). These long kinetics would explain why in the original reports of p75 processing by g-secretase, the authors did not observe any ligand-dependent proteolysis (Jung et al., 2003; Kanning et al., 2003) because they did not analyze the effects of the ligand beyond 1-2 hr. The cleavage kinetics we observed for p75 are much longer than those of Erb-B4 (Ni et al., 2001) and Notch (Berezovska et al., 2000) , suggesting that there are additional signaling events activated by the receptor that are required prior to cleavage. It is notable that the activation of JNK by several cytokines was shown to promote APP and Notch proteolysis by g-secretase (Liao et al., 2004) , and the activation of JNK by p75 in sympathetic neurons occurred over a period of several hours (Palmada et al., 2002; Yeiser et al., 2004) . Alternatively, p75 cleavage may only occur after receptor internalization. The g-secretase-mediated proteolysis of Notch and APP has been suggested to occur after receptor endocytosis (Kanwar and Fortini, 2004; Gupta-Rossi et al., 2004; Chang et al., 2003) , although this remains controversial (Chyung et al., 2005) . Recently, p75 internalization after ligand binding was shown to occur with a long half-life, three times that for TrkA (Bronfman et al., 2003) . Hence, the delayed appearance of the free p75 ICD may be the result of a requirement for p75 localizing to an intracellular compartment prior to cleavage.
One of the mechanisms regulating the internalization and proteolytic processing of Notch is ubiquitination. Several E3 ubiquitin ligases have been shown to modulate Notch signaling at multiple steps; for example, Mindbomb and Neuralized are involved in the activation of Notch ligands, whereas Deltex, Itch, and Nedd4 regulate Notch internalization and trafficking (Le Borgne et al., 2005) . Interestingly, one of the proteins shown to associate with the ICD of p75 is an E3 ubiquitin ligase, TRAF6. Unlike the classical ubiquitin chain, polymerized via lysine 48 of ubiquitin, which targets proteins to the proteasome, TRAF6 catalyzes the formation of a unique chain linked through lysine 63, and this modification appears to serve as a protein interaction motif and not promote degradation (Deng et al., 2000) . We recently found that in response to p75 activation, NRIF undergoes TRAF6-dependent K63 polyubiquitination at lysine 19 and translocates to the nucleus (Geetha et al., 2005) . Mutation of this lysine in NRIF prevented its ubiquitination and nuclear translocation, and, unlike wild-type NRIF, the K19R mutant did not restore p75 mediated apoptosis in nrif 2/2 sympathetic neurons, demonstrating (B) The sympathetic neurons uninfected or infected with adenovirus expressing GFP or the ICD of p75 as in (A) were untreated or pretreated with Compound E (100 nM) for 1 hr. Neurons were fixed 24 hr after adenoviral exposure, stained with DAPI, and the apoptotic nuclei quantified. Shown are the means 6 SD, n = 4 (asterisk, p < 0.001).
(C and D) Sympathetic neurons, incubated with adenovirus expressing GFP or p75 ICD or left uninfected as described above, were immunostained for NRIF after 24 hr (green) and propidium iodide to label nuclei (red). The neurons were then imaged by confocal microscopy (C). Note the overlap of NRIF and nuclear staining in neurons overexpressing the ICD of p75 (arrows). The neurons infected with GFP control vector were also immunostained for NRIF (red). (Scale bar, 20 mm.) The neurons with NRIF immunoreactivity in the nucleus were quantified (D). Shown are the means 6 SD, n = 3 (asterisk, p < 0.0001).
(E and F) Sympathetic neurons were infected with adenovirus expressing GFP or p75 ICD, as described above, the cells were lysed after 24 hr, immunoprecipitated with antisera to the ICD of p75 (E) or NRIF (F), and Western blotted with anti-NRIF or p75 ICD.
(G) 24 hr after infection of the neurons with adenovirus expressing GFP or p75 ICD, the cells were lysed, immunoprecipitated with NRIF antibody, and Western blotted with anti-ubiquitin or anti-NRIF. (H) Sympathetic neurons from traf6 2/2 animals were cultured in 20 ng/ml NGF, incubated with adenovirus expressing GFP or p75 ICD, or left uninfected as described above. 24 hr later, the cells were immunostained for NRIF (green) and propidium iodide to label nuclei (red). The neurons infected with GFP control vector were also immunostained for NRIF (red). The neurons were then imaged by confocal microscopy. (Scale bar, 20 mm.) that polyubiquitination and nuclear translocation of NRIF are required for p75-receptor-mediated neuronal apoptosis. Here, we demonstrate that the release of the ICD is necessary for the ubiquitination of NRIF (Figure 3A) ; indeed, overexpression of this receptor fragment alone was sufficient to induce this modification of NRIF ( Figure 6G ). Taken together, these findings indicate that p75 activation results in receptor cleavage by g-secretase, which releases the ICD, thereby allowing TRAF6 to ubiquitinate NRIF, which facilitates its nuclear translocation.
Experimental Procedures
Cell Culture and Reagents Sympathetic neurons from P3-P4 rats were isolated from the superior cervical ganglia (SCG) and cultured as previously described (Palmada et al., 2002) . All experiments with animals were approved by the Animal Care and Use Committee at Vanderbilt University. HEK293 and RN22 cells were cultured in high glucose DMEM with 10% fetal bovine serum and penicillin/streptomycin (100 U/ml, 100 mg/ml, respectively) and transfected by the standard calcium phosphate method.
Recombinant, furin-resistant proBDNF was prepared as previously described (Pang et al., 2004) . Recombinant BDNF was generously provided by Regeneron, Inc. The p75 antiserum was made with a fusion protein of GST and the full-length ICD.
Neuronal Apoptosis Assay
Sympathetic neurons from P3-P4 rats were cultured in 20 ng/ml of NGF (Harlan) for 2 days, and then NGF was removed, the cells rinsed, and switched to media containing anti-NGF (0.1 mg/ml, Chemicon International) together with 12.5 mM KCl, to promote survival, with or without the addition of 3 ng/ml proBDNF or 100 ng/ml of BDNF for 48 hr. In some experiments, neurons maintained in 12.5 mM KCl were treated with Compound E (kindly provided by Dr. Todd Golde, Mayo Clinic, and Dr. Graham Carpenter, Vanderbilt University) or DAPT (Calbiochem) in the presence and absence of 3 ng/ml of proBDNF or 100 ng/ml of BDNF for 48 hr. Then cells were fixed in 4% paraformaldehyde (PFA) and stained with DAPI (Vector Labs) to score the nuclei as apoptotic or nonapoptotic. Approximately 300 neurons were counted for each condition.
Immunoprecipitation and Western Blotting
Neurons, cultured as above, were treated with 10 mM of the proteasome inhibitor ZLLLH (Peptides International) alone or with the addition of PMA (1mM), proBDNF (3 ng/ml), BDNF (100 ng/ml), or NGF (100 ng/ml) for various times, as indicated. In some experiments, (B) RN22 cells were transfected with HA-p75, HA-p75-FasTM, or left untransfected. After 48 hr, the cells were treated with 10 mM ZLLLH alone or together with 100 ng/ml of BDNF for 12 hr, and then cell lysates were collected and analyzed by Western blot with an anti-p75 ICD. (C) 293 cells were transfected with HA-p75, HA-p75-FasTM, or both, and 48 hr later, the cells were treated with 10 mM ZLLLH alone or together with 100 ng/ml of BDNF for 12 hr. The cells were lysed and Presenilin 1 immunoprecipitated and Western blotted with anti-p75 ICD or anti-Presenilin 1. (D) Sympathetic neurons from P3-P4 rats were transfected with GFP alone or cotransfected with GFP and either HA-p75 or HA-p75-FasTM, by electroporation, and then cultured with NGF (20 ng/ml). After 2 days, the NGF was removed, and the neurons were maintained in media with 12.5 mM KCl alone (empty bars) or with 100 ng/ml of BDNF (black bars). After 48 hr, the cells were stained with DAPI, and the percent of GFP-positive neurons with apoptotic nuclei quantified. Shown are the means 6 SD, n = 3 (asterisk, p < 0.002). (E) Sympathetic neurons were cultured and transfected as described in (D) with either HA-p75 or HA-p75-FasTM. 2 days after transfection, the NGF was removed, and the neurons were maintained in media with 12.5 mM KCl alone (2 proBDNF) or with 3 ng/ml of proBDNF (+ proBDNF) for 30 hr, and then the cells were stained for HA (red) and NRIF (green). (B) Superior cervical ganglia from P4 or P24 were immunostained for NRIF (green) and propidium iodide for nuclei (red). The tissues were then imaged by confocal microscopy (scale bar, 20 mm). (C) Sympathetic neurons from P3-P4 rats were cultured in 20 ng/ml of NGF for 2 days, and then the NGF was removed and neurons were maintained in media lacking NGF containing antibody to NGF. 24 hr later, the cells were lysed and Western blotted with anti-p75 ICD. (D) Sympathetic neurons from P3-P4 rats were cultured with NGF (20 ng/ml) for 2 days, and then the NGF was removed, and after 20 hr, the cells were immunostained for NRIF (green), and the nuclei labeled with propidium iodode (red) and imaged by confocal microscopy (scale bar, 20 mm). the cells were pretreated for 1 hr with the g-secretase inhibitor Compound E or DAPT. Neurons from P3-P4 traf6 2/2 mice (Naito et al., 1999) were also treated with 10 mM ZLLLH alone or with the addition of BDNF (100 ng/ml) for 12 hr. The neurons were then lysed in Laemmli buffer, sonicated, and subjected to Western blot analysis with an antibody to the ICD of p75 or to NRIF (Gentry et al., 2004b) . To detect the ICD of p75 in vivo, we isolated whole SCG from nine animals at P4 or P24.
Transfected 293 cells were treated with 10 mM ZLLLH alone or together with PMA (1mM) for 2 hr or BDNF (100 ng/ml) for 12 hr. The RN22 cells were treated with or without NGF (100 ng/ml) for 2 and 12 hr, or with BDNF (100 ng/ml) for 12 hr, in the presence of 10 mM ZLLLH. For evaluation of the p75 mutants, the 293 or RN22 cells were transfected with wild-type p75, p75-FasTM, or both and 48 hr later, treated with 10 mM ZLLLH alone or along with 100 ng/ml of BDNF for 12 hr. Cells were harvested and lysed in NP-40 lysis buffer (10% glycerol, 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride [PMSF], 2 mg/ml leupeptin and aprotinin), TGH lysis buffer (0.2% Triton X-100, 20 mM HEPES [pH 7.2], 20 mM NaCl, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM Na 3 VO 4 , and 50 mM NaF) for the presenilin 1 immunoprecipitation, or SDS lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10 mM NaF, 0.5% Triton X-100, 1% SDS, 1 mM Na 3 VO 4, 1 mM PMSF, 10 mg/ml leupeptin and aprotinin) for detecting ubiquitin. The lysates were Western blotted with antibodies to the ICD of p75, NRIF, presenilin 1 (SC-7860, Santa Cruz Biotechnology) or HA (1:1000, Roche Applied Sciences).
For immunopreciptitation, the neuron or 293 cell lysates were immunoprecipitated with affinity-purified anti-NRIF, anti-presenilin 1, anti-HA, or anti-p75 ICD and then immunoblotted with an antibody to the ICD of p75 (1:3000), NRIF (1:2000), ubiquitin (1:500, SC-8017, Santa Cruz), Histone deacetylase 1 (1:1000, Santa Cruz), b-actin (1:1000, Santa Cruz), or NRH2 (1:2000, generously provided by Dr. Phil Barker).
Adenoviral Infection of Sympathetic Neurons
Sympathetic neurons from P3-P4 wild-type and traf6 2/2 animals were removed from SCG and cultured as described above in NGF (20 ng/ml) for 2 days and then incubated with adenovirus expressing GFP or the ICD of p75 at dilutions sufficient to give similar levels of infection, based on immunofluorescent detection of the expressed protein. After 24 hr, the neurons were harvested for Western blotting, immunoprecipitation, or fixed in 4% PFA for immunostaining and counting apoptotic nuclei. In some experiments the neurons were treated with Compound E (100 nM) alone or pretreated for 1 hr before incubation with adenovirus expressing the intracellular domain of p75.
NRIF Ubiquitination
For NRIF ubiquitination studies, neurons were treated with BDNF (250 ng /ml) alone for 15 min or 16 hr, or the cells were pretreated for 1 hr with Compound E (100 nM) followed by treatment with BDNF for 16 hr. In some experiments, the neurons were infected with adenovirus expressing GFP or the intracellular domain of p75 for 24 hr. After these treatments, the cells were subjected to Western blot analysis as described above.
Immunostaining
The sympathetic neurons treated with 3 ng/ml of proBDNF as above for 30 hr or infected with adenovirus expressing GFP or p75 ICD for 24 hr were fixed in 4% PFA, permeabilized with 0.1% sodium citrate and 0.1% Triton X-100, blocked with 10% goat serum in PBS, and incubated with the affinity-purified NRIF antibody (1:100 dilution) or p75 ICD antibody (1:100) in PBS containing 0.1% Triton X-100, followed by incubation with anti-rabbit Alexa 488 or 546 (Molecular Probes). Nuclei were visualized by propidium iodide, and images were acquired with a confocal laser imaging system (LSM 510; Carl Zeiss MicroImaging, Inc.) at 4003. The nuclear localization of NRIF was quantified blinded by counting 40-50 neurons for each condition in random confocal images.
For NRIF staining in vivo, SCG's from P4 or P24 mice were removed, fixed in 4% PFA, and cryosections taken at 12 mm thickness. The tissues were processed for immunostaining of NRIF as described above and nuclei were stained by propidium iodide, and images were acquired with the confocal laser imaging system at 6003.
Nuclear Extraction Preparation
Sympathetic neurons, cultured as described above on 60 mm dishes in KCl, were treated with or without 3 ng/ml of proBDNF for 30 hr and nuclear extracts prepared as described by Dignam et al. (1983) . The nuclear extract was then used to immunoprecipitate NRIF.
Transfection of Sympathetic Neurons
Sympathetic neurons from P3-P4 rats were isolated and dissociated as previously described (Palmada et al., 2002 ). The cell suspensions were then transfected with GFP alone or cotransfected with wildtype p75 or p75-FasTM by electroporation with program O-03 on an Amaxa Nucleofactor device. For apoptosis assays, the neurons were treated as described above, and the nuclei of GFP-positive neurons were evaluated to score for apoptosis. In each case, at least 130 neurons were counted. For immunostaining, neurons were transfected with wild-type p75 (HA-p75) or p75-FasTM (HA-p75-FasTM) receptor and treated with 3 ng/ml of proBDNF or untreated for 30 hr, and then the neurons were fixed and immunostained for HA and NRIF with HA mouse monoclonal antibody (1:100, clone 12CA5, Roche Applied Sciences) and affinity-purified NRIF antibody (1:100) and visualized with anti mouse Rhodamine Red (Jackson ImmunoResearch Laboratory, Inc.) and anti rabbit Alexa 488 (Molecular Probes), and images were acquired with a confocal laser imaging system at 4003.
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